1. Home
  2. NX vs FDMT Comparison

NX vs FDMT Comparison

Compare NX & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Quanex Building Products Corporation

NX

Quanex Building Products Corporation

HOLD

Current Price

$20.90

Market Cap

819.4M

Sector

Industrials

ML Signal

HOLD

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

HOLD

Current Price

$10.31

Market Cap

695.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NX
FDMT
Founded
1927
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
819.4M
695.3M
IPO Year
2008
2019

Fundamental Metrics

Financial Performance
Metric
NX
FDMT
Price
$20.90
$10.31
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$28.00
$31.71
AVG Volume (30 Days)
310.8K
620.6K
Earning Date
06-04-2026
05-08-2026
Dividend Yield
1.64%
N/A
EPS Growth
N/A
18.79
EPS
N/A
N/A
Revenue
$1,837,641,000.00
$85,209,000.00
Revenue This Year
$4.26
N/A
Revenue Next Year
$1.77
$70.28
P/E Ratio
N/A
N/A
Revenue Growth
43.81
230194.60
52 Week Low
$11.04
$5.33
52 Week High
$22.90
$14.00

Technical Indicators

Market Signals
Indicator
NX
FDMT
Relative Strength Index (RSI) 66.73 45.85
Support Level $15.52 $9.63
Resistance Level $21.33 $10.74
Average True Range (ATR) 0.89 0.64
MACD 0.27 -0.10
Stochastic Oscillator 91.02 36.58

Price Performance

Historical Comparison
NX
FDMT

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

Share on Social Networks: